Radiation And Your Patient

Advances in Radiogenomics: A Review

Advances in Radiogenomics: A Review

By

Researchers are seeking genetic biomarkers that can predict which patients are most likely to suffer radiotoxicities and which can safely undergo intensified radiation treatment regimens.

Radiation-Induced Esophagitis: A Common, Debilitating Clinical Challenge in Thoracic Radiotherapy

Radiation-Induced Esophagitis: A Common, Debilitating Clinical Challenge in Thoracic Radiotherapy

By

A review of current options and ongoing trials for managing ARIE, a common esophageal adverse effect caused by radiotherapy to the thoracic region for lung, breast, or head and neck cancers, or lymphoma.

Evolving Role of Radiation Therapy in the Treatment of Mesothelioma

Evolving Role of Radiation Therapy in the Treatment of Mesothelioma

By

Research into the potential of radiation therapy in the management of mesothelioma may improve the prognosis, and possibly extend progression-free survival, for patients with this incurable cancer.

Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy

Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy

By

At $225 million per system, the precision of proton beam radiotherapy is not necessarily overshadowing its high costs. Yet ongoing studies seek to determine how this technology fits into current treatment regimens for prostate, breast, and other cancers.

Incorporating Cardiac Care in the Oncology Setting

Incorporating Cardiac Care in the Oncology Setting

By

Cardio-oncology is an emerging interdisciplinary practice poised to address care patients who need concurrent cancer and cardiovascular disease therapies as well as the late effects of cancer and cancer treatments.

Optimal Treatment Regimens for Oldest Patients Is an Emerging Challenge for Radiation Oncology

Optimal Treatment Regimens for Oldest Patients Is an Emerging Challenge for Radiation Oncology

By

A look at the significant influence of age-adjusted prognoses and treatment priorities for radiation therapy in the oldest patients with cancer.

Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases

Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases

By

Palliative radiotherapy for bone metastases is safe, effective — but controversy persists for single-fraction treatment.

GARD: A Move Toward Precision Radiation Therapy

GARD: A Move Toward Precision Radiation Therapy

By

A new tool may enable oncologists to deliver radiation therapy targeted to a tumor's biology and radiosensitivity, similar to how anticancer agents target specific tumor mutation-affected gene pathways.

Gero-Oncology: Preparing for the Coming Wave of Elderly Cancer Patients

Gero-Oncology: Preparing for the Coming Wave of Elderly Cancer Patients

By

A growing proportion of cancer patients are elderly—creating a demographic shift with important implications for cancer care, including radiotherapy. Integrating geriatric care into oncology nursing has never been more important.

PMPS: A Common Late Effect of Surgery and Radiation for Breast Cancer

PMPS: A Common Late Effect of Surgery and Radiation for Breast Cancer

By

Postmastectomy pain syndrome (PMPS) is a debilitating late effect of surgery and radiation therapy for breast cancer.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs